Switch to:

BioSpecifics Technologies Interest Coverage

: No Debt (As of Mar. 2019)
View and export this data going back to 1991. Start your Free Trial

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. BioSpecifics Technologies's Operating Income for the three months ended in Mar. 2019 was USD 5.07 Mil. BioSpecifics Technologies's Interest Expense for the three months ended in Mar. 2019 was USD 0.00 Mil. BioSpecifics Technologies has no debt. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

BioSpecifics Technologies Corp has no debt.

NAS:BSTC' s Interest Coverage Range Over the Past 10 Years
Min: No Debt   Max: No Debt
Current: No Debt


NAS:BSTC's Interest Coverage is ranked higher than
99% of the 444 Companies
in the Biotechnology industry.

( Industry Median: 10000.00 vs. NAS:BSTC: No Debt )

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


BioSpecifics Technologies Interest Coverage Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

BioSpecifics Technologies Annual Data

Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Interest Coverage Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt No Debt No Debt No Debt

BioSpecifics Technologies Quarterly Data

Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Interest Coverage Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt No Debt No Debt No Debt

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


BioSpecifics Technologies Interest Coverage Distribution

* The bar in red indicates where BioSpecifics Technologies's Interest Coverage falls into.



BioSpecifics Technologies Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1*Operating Income/Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt.


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BioSpecifics Technologies's Interest Coverage for the fiscal year that ended in Dec. 2018 is calculated as

Here, for the fiscal year that ended in Dec. 2018, BioSpecifics Technologies's Interest Expense was USD 0.00 Mil. Its Operating Income was USD 23.40 Mil. And its Long-Term Debt & Capital Lease Obligation was USD 0.00 Mil.

BioSpecifics Technologies had no debt.

BioSpecifics Technologies's Interest Coverage for the quarter that ended in Mar. 2019 is calculated as

Here, for the three months ended in Mar. 2019, BioSpecifics Technologies's Interest Expense was USD 0.00 Mil. Its Operating Income was USD 5.07 Mil. And its Long-Term Debt & Capital Lease Obligation was USD 0.00 Mil.

BioSpecifics Technologies had no debt.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

The higher the ratio, the stronger the company's Financial Strength is.


BioSpecifics Technologies  (NAS:BSTC) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


BioSpecifics Technologies Interest Coverage Explanation


BioSpecifics Technologies Interest Coverage Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}